Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariane Herrick

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
The Journal of Rheumatology|March 15, 2013
Dr. Murray, et al replyAndrea K Murray, Christopher E M Griffiths, Ariane Herrick
Kidney International|April 17, 2016
Simple tool in a complex case: use of the nailfold capillaroscopyThilini Abeygunaratne, Ariane Herrick, Hector Chinoy, et al.
Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention|October 22, 2014
An automated system for detecting and measuring nailfold capillariesMichael Berks, Phil Tresadern, Graham Dinsdale, et al.
Clinical and Experimental Rheumatology|November 6, 2014
Consensus best practice pathway of the UK scleroderma study group: gastrointestinal manifestations of systemic sclerosisNavjyot Hansi, Nora Thoua, Maresa Carulli, et al.
Clinical Rheumatology|December 21, 2013
Consensus opinion of a North American Working Group regarding the classification of digital ulcers in systemic sclerosisMurray Baron, Lorinda Chung, Geneviève Gyger, et al.
BMC Musculoskeletal Disorders|February 8, 2012
Pressure and pain in systemic sclerosis/scleroderma--an evaluation of a simple intervention (PISCES): randomised controlled trial protocolBegonya Alcacer-Pitarch, Maya H Buch, Janine Gray, et al.
Arthritis and Rheumatism|April 29, 2008
Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trialPeter A Merkel, Nancy P Silliman, Christopher P Denton, et al.
Arthritis and Rheumatism|December 30, 2006
Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192Christopher P Denton, Peter A Merkel, Daniel E Furst, et al.
The Journal of Rheumatology|November 3, 2011
Polymorphisms in the interleukin 4, interleukin 13, and corresponding receptor genes are not associated with systemic sclerosis and do not influence gene expressionJasper C A Broen, Phillipe Dieude, Madelon C Vonk, et al.
The Journal of Rheumatology|June 17, 2010
Functional variants of Fc gamma receptor (FCGR2A) and FCGR3A are not associated with susceptibility to systemic sclerosis in a large European Study (EUSTAR)Behrooz Z Alizadeh, Jasper Broen, Blanca Rueda, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
The Journal of Rheumatology|March 15, 2013
Dr. Murray, et al replyAndrea K Murray, Christopher E M Griffiths, Ariane Herrick
Kidney International|April 17, 2016
Simple tool in a complex case: use of the nailfold capillaroscopyThilini Abeygunaratne, Ariane Herrick, Hector Chinoy, et al.
Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention|October 22, 2014
An automated system for detecting and measuring nailfold capillariesMichael Berks, Phil Tresadern, Graham Dinsdale, et al.
Clinical and Experimental Rheumatology|November 6, 2014
Consensus best practice pathway of the UK scleroderma study group: gastrointestinal manifestations of systemic sclerosisNavjyot Hansi, Nora Thoua, Maresa Carulli, et al.
Clinical Rheumatology|December 21, 2013
Consensus opinion of a North American Working Group regarding the classification of digital ulcers in systemic sclerosisMurray Baron, Lorinda Chung, Geneviève Gyger, et al.
BMC Musculoskeletal Disorders|February 8, 2012
Pressure and pain in systemic sclerosis/scleroderma--an evaluation of a simple intervention (PISCES): randomised controlled trial protocolBegonya Alcacer-Pitarch, Maya H Buch, Janine Gray, et al.
Arthritis and Rheumatism|April 29, 2008
Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trialPeter A Merkel, Nancy P Silliman, Christopher P Denton, et al.
Arthritis and Rheumatism|December 30, 2006
Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192Christopher P Denton, Peter A Merkel, Daniel E Furst, et al.
The Journal of Rheumatology|November 3, 2011
Polymorphisms in the interleukin 4, interleukin 13, and corresponding receptor genes are not associated with systemic sclerosis and do not influence gene expressionJasper C A Broen, Phillipe Dieude, Madelon C Vonk, et al.
The Journal of Rheumatology|June 17, 2010
Functional variants of Fc gamma receptor (FCGR2A) and FCGR3A are not associated with susceptibility to systemic sclerosis in a large European Study (EUSTAR)Behrooz Z Alizadeh, Jasper Broen, Blanca Rueda, et al.
Pageof 5